| Home \ Media \ Media Coverage |
|
Media Coverage
Search for:
in:
Public Service Europe
Recasting the welfare state for the 21st century – best-practice models
Date: 08 March 2011
 Public Finance Blog
Welfare reform: can it work?
Date: 17 February 2011
Helen Disney discusses the coalition government`s plans for a radical shake-up of the British welfare state as the Stockholm Network gets set to host an event on the future of the welfare state after the financial crisis.
This article was first published on the PF Blog website on 17th February 2011. The article can be view online at: The Guardian
This reform of NHS drug funding is not a sweet deal for big pharma
Date: 17 November 2010
Polly Toynbee (Forget patients. Andrew Lansley is the servant of big pharma, 2 November) attacks the reform of the National Institute for Health and Clinical Excellence (Nice) as "offering a health service without limits just when the NHS is to be cut back as never before".
This statement is misleading and deserves to be unpacked. British Medical Journal
Legitimacy of think tanks
Date: 17 November 2010
Steve Harkins and Melissa Jones question the ability of the Stockholm Network to produce independent research since we receive funding from the pharmaceutical industry.
I entirely agree that funding sources for research carried out by policy-making organisations such as think tanks ought to be transparent wherever possible. We are funded by memberships and research grants from a range of companies, foundations and individuals. Not only do we not hide this, but we list all sponsors on our website and in our annual reports. In fact, most of the material cited by Harkins and Jones as evidence for our industry bias is provided by our own reports. This allows people to reach their own conclusions regarding our work, both in light of our funding, but most importantly from its substance. However Harkins and Jones`s criticism is aimed purely at our (openly declared) funding, not at the substance of what we say - this is, after all, the easier target. PharmaTimes
Govt cautioned over risk-sharing schemes
Date: 09 November 2010
The risk-sharing schemes now being used as a way of increasing access to medicines are very much in their infancy and should not form the basis for more widespread use in the NHS, a new report warns. The UK government must re-assess such schemes before making the National Institute for Health and Clinical Excellence (NICE) “redundant,” says the study, which is published by the Stockholm Network, a European pro-market think tank.
|
Download the full article: Recasting the welfare state for the 21st century – best-practice models